The data on cannabis and its components for treatment of neurological disorders are plentiful, according to Michele Faulkner, PharmD, FASHP. “Cannabis is a huge topic,” said Faulkner during an APhA2021 Virtual session products treat disorders.Most pharmacists probably familiar with as epilepsy. In 2018, FDA approved Epidiolex (Greenwich Biosciences) the first-ever product containing cannabidiol...